These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 9562781)

  • 1. [HIV-1 protease inhibitors in review].
    Hilgeroth A
    Pharm Unserer Zeit; 1998 Jan; 27(1):22-5. PubMed ID: 9562781
    [No Abstract]   [Full Text] [Related]  

  • 2. Development of protease inhibitors and the fight with drug-resistant HIV-1 variants.
    Mitsuya H; Maeda K; Das D; Ghosh AK
    Adv Pharmacol; 2008; 56():169-97. PubMed ID: 18086412
    [No Abstract]   [Full Text] [Related]  

  • 3. HIV protease inhibitors: peptidomimetic drugs and future perspectives.
    Abdel-Rahman HM; Al-karamany GS; El-Koussi NA; Youssef AF; Kiso Y
    Curr Med Chem; 2002 Nov; 9(21):1905-22. PubMed ID: 12369875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical benefits of resistance assay for HIV-specific protease inhibitors: when to check and in whom?
    Aizawa S; Gatanaga H; Ida S; Sakai A; Tanaka M; Takahashi Y; Hirabayashi Y; Oka S
    AIDS; 1999 Jul; 13(10):1278-9. PubMed ID: 10416536
    [No Abstract]   [Full Text] [Related]  

  • 5. Inhibitors of HIV-1 protease.
    Meek TD
    J Enzyme Inhib; 1992; 6(1):65-98. PubMed ID: 1285304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-resistance within the protease inhibitor class.
    Race E
    Antivir Ther; 2001; 6 Suppl 2():29-36. PubMed ID: 11678476
    [No Abstract]   [Full Text] [Related]  

  • 7. A 6-base pair insertion in the protease gene of HIV type 1 detected in a protease inhibitor-naive patient is not associated with indinavir treatment failure.
    Stürmer M; Staszewski S; Doerr HW; Hertogs K
    AIDS Res Hum Retroviruses; 2003 Nov; 19(11):967-8. PubMed ID: 14678603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimization of a macromolecular inhibitor of HIV-1 protease.
    Dauber DS; McPhee F; Unal A; Craik CS
    Adv Exp Med Biol; 1998; 436():65-70. PubMed ID: 9561201
    [No Abstract]   [Full Text] [Related]  

  • 9. Perspectives in HIV protease inhibitors.
    Leonard JM
    Adv Exp Med Biol; 1996; 394():319-25. PubMed ID: 8815696
    [No Abstract]   [Full Text] [Related]  

  • 10. AIDS drugs lurch towards market.
    Steele F
    Nat Med; 1995 Apr; 1(4):285-6. PubMed ID: 7585051
    [No Abstract]   [Full Text] [Related]  

  • 11. Update of the drug resistance mutations in HIV-1: 2004.
    Johnson VA; Brun-Vézinet F; Clotet B; Conway B; D'Aquila RT; Demeter LM; Kuritzkes DR; Pillay D; Schapiro JM; Telenti A; Richman DD
    Top HIV Med; 2004; 12(4):119-24. PubMed ID: 15516709
    [No Abstract]   [Full Text] [Related]  

  • 12. A fast and robust 19F NMR-based method for finding new HIV-1 protease inhibitors.
    Frutos S; Tarrago T; Giralt E
    Bioorg Med Chem Lett; 2006 May; 16(10):2677-81. PubMed ID: 16517158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human immunodeficiency virus. Protease uninhibited.
    Richman DD
    Nature; 1995 Apr; 374(6522):494. PubMed ID: 7700370
    [No Abstract]   [Full Text] [Related]  

  • 14. HIV-1 protease inhibitors: development, status, and potential role in the treatment of AIDS.
    Lang M; Roesel J
    Arch Pharm (Weinheim); 1993 Dec; 326(12):921-4. PubMed ID: 8122962
    [No Abstract]   [Full Text] [Related]  

  • 15. Highly active antiretroviral therapy failure and protease and reverse transcriptase human immunodeficiency virus type 1 gene mutations.
    Monno L; Appice A; Cavaliere R; Scarabaggio T; Angarano G
    J Infect Dis; 1999 Aug; 180(2):568-71. PubMed ID: 10395885
    [No Abstract]   [Full Text] [Related]  

  • 16. [Tipranavir: therapeutic drug monitoring in a pediatric patient with HIV infection].
    Soler-Palacín P; Fàbrega A; María López R; Figueras C
    Enferm Infecc Microbiol Clin; 2009 Feb; 27(2):133-4. PubMed ID: 19254645
    [No Abstract]   [Full Text] [Related]  

  • 17. Tipranavir: a protease inhibitor for multi-drug resistant HIV-1.
    Best B; Haubrich R
    Expert Opin Investig Drugs; 2006 Jan; 15(1):59-70. PubMed ID: 16370934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-HIV protease activity from rosa family plant extracts and rosamultin from Rosa rugosa.
    Park JC; Kim SC; Choi MR; Song SH; Yoo EJ; Kim SH; Miyashiro H; Hattori M
    J Med Food; 2005; 8(1):107-9. PubMed ID: 15857219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitors of HIV-1 protease containing the novel and potent (R)-(hydroxyethyl)sulfonamide isostere.
    Vazquez ML; Bryant ML; Clare M; DeCrescenzo GA; Doherty EM; Freskos JN; Getman DP; Houseman KA; Julien JA; Kocan GP
    J Med Chem; 1995 Feb; 38(4):581-4. PubMed ID: 7861404
    [No Abstract]   [Full Text] [Related]  

  • 20. Peptidomimetic inhibitors complexed with HIV-1 protease: crystallisation for X-ray diffraction studies.
    Dohnálek J; Hasek J; Brynda J; Fábry M; Sedlácek J; Konvalinka J; Hradilek M; Soucek M; Adams MJ; Naylor CE
    Gen Physiol Biophys; 1998 Jun; 17 Suppl 1():9-11. PubMed ID: 9789742
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.